Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SciClone Pharmaceuticals Inc (NASDAQ:SCLN)

9.11
Delayed Data
As of 3:59pm ET
 -0.045 / -0.49%
Today’s Change
4.81
Today|||52-Week Range
11.71
+3.94%
Year-to-Date
No recent news for SciClone Pharmaceuticals Inc.

Today’s Trading

Previous close9.15
Today’s open9.19
Day’s range8.98 - 9.26
Volume191,435
Average volume (3 months)520,373
Market cap$453.9M
Dividend yield--
Data as of 3:59pm ET, 08/04/2015

Growth & Valuation

Earnings growth (last year)+140.00%
Earnings growth (this year)+20.83%
Earnings growth (next 5 years)+14.70%
Revenue growth (last year)+6.09%
P/E ratio15.9
Price/Sales3.42
Price/Book2.94

Competitors

 Today’s
change
Today’s
% change
MRTXMirati Therapeutics ...-0.11-0.39%
PRTKParatek Pharmaceutic...+0.20+0.78%
LIFEaTyr Pharma Inc+0.44+2.26%
VTLVital Therapies Inc-0.81-4.38%
Data as of 3:59pm ET, 08/04/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)$0.13
Annual revenue (last year)$134.8M
Annual profit (last year)$25.2M
Net profit margin18.70%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Friedhelm Blobel
Chief Financial Officer &
Senior Vice President
Wai-Shun Wilson Cheung
Corporate headquarters
Foster City, California

Forecasts